Abstract Endovenous laser ablation (EVLA) obliterates incompetent truncal veins as an alternative to varicose veins surgery. We describe 3 patients who developed an arterio-venous fistula (AVF) following great (GSV: 1) or small (SSV: 2) saphenous vein EVLA. Two fistulae closed spontaneously with conservative management.
Introduction
Minimally invasive techniques are increasingly popular for treating varicose veins. EVLA causes thermal obliteration of the target vein with GSV or SSV occlusion in 88e100% 1 and 96e100% 2, 3 of limbs respectively. Whilst complications appear less than after conventional surgery 4 we describe 3 patients who developed an AVF following treatment.
Report
Three of >1500 patients (<0.2%) with primary varicose veins (A: 62 y, female; B: 70 y, male; C: 56 y, female) who underwent EVLA (810 nm diode laser, 12 W power, tumescent anaesthesia) for sapheno-femoral (SFJ) and GSV (A) or sapheno-popliteal (SPJ) and SSV incompetence (B & C) are presented. Treatment and follow-up (duplex ultrasound: DUS) details and Aberdeen Varicose Vein Severity Scores (AVVSS) are shown in Table 1 . No procedural difficulties were encountered.
In patient A DUS (6 weeks) confirmed GSV occlusion, symptoms had improved and sclerotherapy was performed for residual varicosities. Although an AVF was not identified (probably missed) DUS at 12 weeks showed pulsatile SFJ flow fed by a branch of the inferior epigastric artery. There were no recurrent varicose veins or symptoms. Management was expectant and whilst the AVF remains patent (with reducing peak flow velocities: Table 2 ) this remains the case at 18-month follow-up.
An AVF was identified in B & C (DUS: pulsatile popliteal vein flow, no deep vein thrombosis, SSV ablation) at 6 weeks ( Fig. 1) . B reported leg swelling (compression stocking prescribed) but C was asymptomatic. Neither had residual varicosities. DUS at 12 weeks confirmed spontaneous AVF closure in both patients and the oedema in B had resolved.
All 3 patients showed the expected reduction in AVVSS.
Discussion
AVF has been reported once following SSV EVLA 5 but not after GSV ablation. The high laser-tip temperature could cause vein wall perforation with concomitant arterial injury to an adjacent vessel. This risk is presumably greater if tumescent anaesthesia fails to separate the vein from an arterial branch even when laser energy is within the recommended range. It is also conceivable that needle puncture of the vein and a small artery may occur during administration of tumescent anaesthesia. There are no reports of AVF after VNUS â or US-guided foam sclerotherapy.
Clinical recognition of an AVF may be difficult when haemodynamic effects are minimal and it may be missed without thorough ultrasound examination. However, pulsatile venous flow on colour DUS and an abnormal Doppler spectral trace (DST: Fig. 1 ) confirm the diagnosis. The arterial source of the AVF was identified in A but not in B and C. Simultaneous pulsatile flow in the vein and an adjacent artery suggest that the AVF is close to the study point or that the communication is large. Finally, reversed flow on the DST (Fig. 1) indicates that the AVF is distal to the assessment point.
The DST also provides some information about the size of the fistula with lower venous velocities suggesting a smaller AVF and vice versa. Since patients A & C were asymptomatic and B only reported mild swelling of the leg it is likely that these fistulae were small.
Further investigation (angiography) is only required if intervention is considered for marked limb oedema, recurrent varicose veins, venous complications (phlebitis, eczema, lipodermatosclerosis, ulceration), claudication from a steal syndrome or heart failure (high volume shunt).
From the patients presented here it seems likely that fistulae following SSV EVLA are small and will close spontaneously. Although the AVF occurring after GSV EVLA remained patent at 18 months, it was clinically insignificant with decreasing flow velocities.
For the future, longer wave-length diode lasers (1470 nm) may allow a reduction in the laser energy required for successful EVLA and thus reduce the risk of this complication.
Careful follow-up DUS should be used both to confirm target vein occlusion and to exclude complications (deep vein thrombosis, AVF). AVF occurring after GSV or SSV EVLA are unlikely to be clinically significant and should resolve spontaneously. DUS confirms the diagnosis and further investigation is not warranted in the absence of 
